Allergic mechanisms involve the immune system's aberrant response to usually harmless substances, leading to allergic reactions. Sensitization occurs when an individual is exposed to an allergen, prompting the immune system to produce specific antibodies, mainly immunoglobulin E (IgE). Upon subsequent exposure to the same allergen, IgE antibodies trigger the release of various chemical mediators, such as histamine, from mast cells and basophils. Histamine and other mediators cause the characteristic symptoms of allergies, including itching, swelling, and inflammation. The process involves the activation of immune cells, particularly T-helper 2 (Th2) cells, which release cytokines that promote the production of IgE antibodies. Allergic reactions can manifest in various forms, such as allergic rhinitis, asthma, atopic dermatitis, and anaphylaxis. The genetic predisposition, environmental factors, and the type of allergen influence the development and severity of allergic responses. Understanding allergic mechanisms is crucial for diagnosis and treatment. Allergy testing, including skin tests and blood tests, helps identify specific allergens. Management strategies include allergen avoidance, pharmacotherapy with antihistamines and corticosteroids, and immunotherapy to modify the immune response. Ongoing research aims to uncover new insights into allergic mechanisms, paving the way for more targeted and effective allergy treatments.
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Post COVID-19 syndrome is associated with sex and severity of first COVID-19 episode in Honduras
Manuel Antonio Sierra Santos, Central American Technological University, Honduras
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : Development of a platform UPLC-CAD method for high-throughput lipid quantitation and characterization in novel mRNA LNPs
Janet Muzulu, Sanofi, United States
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom